(secondQuint)A Phase 1, Open-label Safety Study of NKA in Patients With Type 2 Diabetes.

 This is a Phase 1 safety and tolerability study to determine if NKA, manufactured from a patient's renal biopsy tissue, can be safely implanted back into the kidney of the patient.

 Patients must have CKD and Type 2 Diabetes.

.

 A Phase 1, Open-label Safety Study of NKA in Patients With Type 2 Diabetes@highlight

The purpose of this study is to determine if selected renal cells, obtained by biopsy from a patient with chronic kidney disease (CKD) and Type 2 Diabetes (i.

e.

, autologous cells) can be safely implanted back into the patient.

